Global CD40 Ligand Market Survey and Trend Research 2018

June 2018 | 83 pages | ID: GB6D6680C7BEN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Biogen, Inc., Bristol-Myers Squibb Company, eTheRNA Immunotherapies NV, ImmuNext, Inc., MedImmune, LLC, MedImmune, LLC, Targovax AS, XL-protein GmbH etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 CD40 Ligand Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 CD40 LIGAND MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Biogen, Inc. (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Bristol-Myers Squibb Company (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 eTheRNA Immunotherapies NV (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 ImmuNext, Inc. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 MedImmune, LLC (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 MedImmune, LLC (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Targovax AS (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 XL-protein GmbH (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global CD40 Ligand Market 2012-2017, by Type, in USD Million
Table Global CD40 Ligand Market 2012-2017, by Type, in Volume
Table Global CD40 Ligand Market Forecast 2018-2023, by Type, in USD Million
Table Global CD40 Ligand Market Forecast 2018-2023, by Type, in Volume
Table Biogen, Inc. Overview List
Table CD40 Ligand Business Operation of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table CD40 Ligand Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table eTheRNA Immunotherapies NV Overview List
Table CD40 Ligand Business Operation of eTheRNA Immunotherapies NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ImmuNext, Inc. Overview List
Table CD40 Ligand Business Operation of ImmuNext, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC Overview List
Table CD40 Ligand Business Operation of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC Overview List
Table CD40 Ligand Business Operation of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Targovax AS Overview List
Table CD40 Ligand Business Operation of Targovax AS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table XL-protein GmbH Overview List
Table CD40 Ligand Business Operation of XL-protein GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global CD40 Ligand Sales Revenue 2012-2017, by Companies, in USD Million
Table Global CD40 Ligand Sales Revenue Share, by Companies, in USD Million
Table Global CD40 Ligand Sales Volume 2012-2017, by Companies, in Volume
Table Global CD40 Ligand Sales Revenue Share, by Companies in 2017, in Volume
Table CD40 Ligand Demand 2012-2017, by Application, in USD Million
Table CD40 Ligand Demand 2012-2017, by Application, in Volume
Table CD40 Ligand Demand Forecast 2018-2023, by Application, in USD Million
Table CD40 Ligand Demand Forecast 2018-2023, by Application, in Volume
Table Global CD40 Ligand Market 2012-2017, by Region, in USD Million
Table Global CD40 Ligand Market 2012-2017, by Region, in Volume
Table CD40 Ligand Market Forecast 2018-2023, by Region, in USD Million
Table CD40 Ligand Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure CD40 Ligand Industry Chain Structure
Figure Global CD40 Ligand Market Growth 2012-2017, by Type, in USD Million
Figure Global CD40 Ligand Market Growth 2012-2017, by Type, in Volume
Figure Global CD40 Ligand Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global CD40 Ligand Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region